PACKAGE LEAFLET: INFORMATION FOR THE USER RENNIE DUAL ACTION TABLETS. Calcium carbonate, Magnesium carbonate, Alginic acid Chewable tablets

Similar documents
Package Leaflet: Information for the User. Read all of this leaflet carefully because it contains important information for you.

2. What you need to know before you take DDAVP/Desmopressin Tablets

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET. Calcichew* 500 mg Chewable Tablets calcium carbonate

Package leaflet: Information for the User Clarityn 10 mg tablets Loratadine

PACKAGE LEAFLET: INFORMATION FOR THE USER. <PRODUCT NAME> 600 mg / 1,000 IU orodispersible tablets. Calcium/cholecalciferol (Vitamin D3)

Package leaflet: Information for the user. Burinex 5 mg Tablets bumetanide

Package leaflet: Information for the user. Calcichew-D 3 Melon 500 mg/1000 IU chewable tablets calcium/cholecalciferol (vitamin D 3 )

Package leaflet: Information for the user. Calcichew-D 3 Citron 500 mg/1000 IU chewable tablets calcium/cholecalciferol (vitamin D 3 )

Ca-C 1000 Calvive 1000 mg mg mg effervescent tablets

Package leaflet: Information for the user. Colecalciferol 3000 IU/ml Oral Solution (colecalciferol)

Package leaflet: Information for the patient. Histaclar 10 mg Film-coated Tablets loratadine

Package leaflet: Information for the User Clarityn 1 mg/ml syrup Loratadine

PACKAGE LEAFLET: INFORMATION FOR THE USER

Dulcolax 5 mg, film-coated tablets

Package leaflet: Information for the user Phosex 1000 mg Tablets Calcium acetate

1. What Betahistine dihydrochloride tablets is and what it is used for

Package leaflet: Information for the use. Calcichew-D3 Citron 500 mg/400 IU chewable tablets calcium / cholecalciferol (vitamin D3)

Package leaflet: Information for the user. Lycimor 300 mg Hard Capsules Lymecycline (equivalent to 300mg of tetracycline base)

PACKAGE LEAFLET: INFORMATION FOR THE USER. EASOFEN MAX STRENGTH 400mg FILM-COATED TABLETS. Ibuprofen

Package leaflet: Information for the patient. Flynise 5 mg Orodispersible Tablets desloratadine

1. What Octostim Nasal Spray is and what it is used for

Package leaflet: Information for the user. Resolor 1 mg film-coated tablets Resolor 2 mg film-coated tablets prucalopride

THORENS I.U. /2.5 ml oral solution. Cholecalciferol (vitamin D 3 )

PATIENT INFORMATION LEAFLET

Atrosan Devil s Claw film-coated tablets

Package leaflet: Information for the user. Floxapen 250 mg & 500 mg Capsules. Flucloxacillin

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. Estracyt Capsules Estramustine phosphate 140mg (as estramustine sodium phosphate)

Package leaflet: Information for the user. Omnilax 10 g powder for oral solution, sachet. Macrogol 4000

Package leaflet: Information for the patient. Forxiga 5 mg film-coated tablets Forxiga 10 mg film-coated tablets dapagliflozin

PACKAGE LEAFLET: INFORMATION FOR THE USER ZIRPINE 10mg TABLETS Cetirizine dihydrochloride

Asacolon 400 mg and 800 mg Gastro-resistant Tablets

Package leaflet: Information for the patient. Vertigon 8 mg Tablets Vertigon 16 mg Tablets (betahistine dihydrochloride)

PYRIDOSTIGMINE LIME TM 60MG TABLETS Pyridostigmine bromide

Package leaflet: Information for the user. Compound Macrogol Oral Powder Sugar Free

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT

Package leaflet: Information for the patient. Velphoro 500 mg chewable tablets Iron as sucroferric oxyhydroxide

Package leaflet: Information for the user

Package leaflet: Information for the user. <PRODUCT NAME> 10 g powder for oral solution in sachet Macrogol 4000

Package leaflet: Information for the patient. Bumetanide 1 mg and 5 mg Tablets (bumetanide)

PACKAGE LEAFLET: INFORMATION FOR THE USER. Tantum Verde orange-honey taste 3 mg lozenges Benzydamine Hydrochloride

Package Leaflet: Information for the user Laxido Paediatric Plain 6.9 g, powder for oral solution

Package leaflet: Information for the patient

Package leaflet: Information for the user. Raxone 150 mg film-coated tablets idebenone

PACKAGE LEAFLET: INFORMATION FOR THE USER. Bydureon 2 mg powder and solvent for prolonged-release suspension for injection in pre-filled pen exenatide

PACKAGE LEAFLET: INFORMATION FOR THE USER. DUKORAL suspension and effervescent granules for oral suspension Cholera vaccine (inactivated, oral)

Package leaflet: Information for the patient

Ascorbic Acid. Dr. Scheffler Vitamin C effervescent tablets are used for the treatment of vitamin C deficiency diseases (e. g. scurvy).

Package Leaflet: Information for the User. BENETOR 10 mg, 20 mg, 40 mg Film-Coated Tablets olmesartan medoxomil

Maxilief Effervescent Tablets

Package leaflet: Information for the user. Zomig 2.5 mg tablets zolmitriptan

Public Assessment Report. Mutual Recognition Procedure

PACKAGE LEAFLET: INFORMATION FOR THE USER. DF118 Tablets 30mg (Dihydrocodeine Hydrogen Tartrate)

PACKAGE LEAFLET: INFORMATION FOR THE USER. altavitad3 25,000 IU oral solution colecalciferol

Package leaflet: Information for the user. Ebateva 20 mg Orodispersible Tablets. Ebastine

PACKAGE LEAFLET: INFORMATION FOR THE USER. GRAZAX 75,000 SQ-T oral lyophilisate

Package Leaflet: Information for the Patient. FOSRENOL 750 mg chewable tablets. FOSRENOL 1000 mg chewable tablets. lanthanum

Ranitic 75mg Film-coated Tablets Ranitidine (as hydrochloride)

Package leaflet: Information for the patient. Olumiant 2 mg film-coated tablets Olumiant 4 mg film-coated tablets Baricitinib

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

PATIENT INFORMATION LEAFLET

Pravat 40 mg tablets. Pravastatin sodium

PACKAGE LEAFLET: INFORMATION FOR THE USER. Finasteride 5mg Film-coated Tablets. (Finasteride) This medicine is for use in men only

Package leaflet: Information for the patient. Calcium Folinate 15 mg Tablets calcium folinate

Package leaflet: Information for the user. Calciflex-D 3 Citron 500 mg/400 IU film-coated tablets calcium/cholecalciferol (vitamin D 3 )

Package leaflet: Information for the user. Nocdurna 25 microgram oral lyophilisate Nocdurna 50 microgram oral lyophilisate.

PACKAGE LEAFLET DIASTABOL 50 MG TABLETS. Version 1.0 1

Package leaflet: Information for the patient. Loratadine 10 mg Tablets (loratadine)

Package leaflet: Information for the patient. Onglyza 2.5 mg film-coated tablets Onglyza 5 mg film-coated tablets Saxagliptin

Zofran tablets contain a medicine called ondansetron. This belongs to a group of medicines called anti-emetics.

Package leaflet: Information for the patient Komboglyze 2.5 mg/1,000 mg film-coated tablets saxagliptin/metformin

Package leaflet: Information for the user. Clopidogrel 75 mg film-coated tablets clopidogrel

Sibelium 5 mg Tablets flunarizine

Package Leaflet: Information for the Patient. FOSRENOL 750 mg oral powder. FOSRENOL 1000 mg oral powder. lanthanum

Package leaflet: Information for the user. Dalmevin 50 mg tablets Vildagliptin

PACKAGE LEAFLET: INFORMATION FOR THE USER. Dantrium 25 mg Capsules / Dantrium 100 mg Capsules Dantrolene sodium

Package leaflet: Information for the patient

Package Leaflet: Information for the user. Digestisan oral drops

Package leaflet: Information for the user. Cefixime ABR 100 mg/5 ml powder for oral suspension Cefixime

Package leaflet: Information for the patient. Metformin Teva 1000 mg Film-coated Tablets Metformin hydrochloride

PACKAGE LEAFLET: INFORMATION FOR THE USER

PACKAGE LEAFLET: INFORMATION FOR THE USER Paracodin 0.20% w/w Syrup (dihydrocodeine hydrogen tartrate)

Package leaflet: Information for the user. Sebivo 600 mg film-coated tablets Telbivudine

Package leaflet: Information for the patient. Risedronate sodium 35 mg film-coated tablets. Risedronate sodium

Package leaflet: Information for the patient

PACKAGE LEAFLET: INFORMATION FOR THE USER

Package Leaflet: Information for the User

Dialosa 1 mg, 2 mg, 3 mg, 4 mg and 6 mg tablets Glimepiride

Package leaflet: Information for the User

Package leaflet: Information for the patient. Selenium 10 micrograms/ml concentrate for solution for infusion. Sodium selenite

PACKAGE LEAFLET: INFORMATION FOR THE USER. Venaforce Varicose Veins gastro-resistant tablets Horse Chestnut seed dry extract

Package leaflet: Information for the user. Irprestan 150 mg film-coated tablets. Irprestan 300 mg film-coated tablets irbesartan

Package leaflet: Information for the patient LOCABIOTAL Pressurised 125 micrograms Nasal/Oromucosal spray solution Fusafungine

PATIENT INFORMATION LEAFLET Cyclophosphamide 50 mg Tablets Cyclophosphamide monohydrate

Package leaflet: Information for the patient

PACKAGE LEAFLET: INFORMATION FOR THE USER. Folic Acid 2.5mg/5ml Oral Solution Folic Acid 2.5mg/5ml

Package leaflet: Information for the user

Transcription:

PACKAGE LEAFLET: INFORMATION FOR THE USER RENNIE DUAL ACTION TABLETS Calcium carbonate, Magnesium carbonate, Alginic acid Chewable tablets Read all of this leaflet carefully because it contains important information for you. This medicine is available without prescription. However, you still need to take Rennie Dual Action Tablets carefully to get the best results from them. Keep this leaflet, you may need to read it again. Ask your pharmacist if you need more information or advice. You must contact a doctor if your symptoms worsen or do not improve after 7 days. If you have any unusual effects after taking Rennie Dual Action, please tell your doctor or pharmacist. In this leaflet 1. What are Rennie Dual Action Tablets and what are they used for? 2. Before you take Rennie Dual Action Tablets 3. How to take Rennie Dual Action Tablets 4. Possible side effects 5. How to store Rennie Dual Action Tablets 6. Further information 1. WHAT ARE RENNIE DUAL ACTION TABLETS AND WHAT ARE THEY USED FOR? Rennie Dual Action tablets provide relief from heartburn and acid indigestion. Rennie Dual Action tablets work in two different ways: 1. Alginic acid forms a protective barrier in the stomach to stop acid escaping upwards, soothing that burning pain in your chest 2. Calcium carbonate and magnesium carbonate provide rapid and long lasting neutralization of excess acid in the stomach 2. BEFORE YOU TAKE RENNIE DUAL ACTION TABLETS Do not take Rennie Dual Action Tablets: If you have severe kidney disease or suffer from kidney stones. If you have high calcium or low phosphate levels in the blood. If you are allergic (hypersensitive) to any of the ingredients. Take special care with Rennie Dual Action Tablets: As with other antacid products, taking these tablets can mask the symptoms of other, more serious, underlying medical conditions. If symptoms persist after seven days consult your doctor. Patients aged 55 years or older with unexplained and persistent heartburn should contact their doctor before taking Rennie Dual Action Tablets. PIL version 1.10, March 2015 1/5

Please consult your doctor or pharmacist before taking Rennie Dual Action Tablets if you have any kidney problems, have been diagnosed with sarcoidosis (inflammation disease that affects multiple organs in the body), or suffer from severe or chronic gastro-intestinal symptoms or diseases. Rennie is designed to help relieve pain and discomfort associated with excess stomach acid. Pain/discomfort associated with cardiac conditions may on occasion mimic indigestion; such pain will not respond to Rennie, therefore it is recommended that medical advice be sought if the pain does not go away. Taking Rennie Dual Action Tablets with food and drink As with all calcium containing antacid products intake with large amounts of milk or dairy products should be refrained. Taking other medicines: Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. If taking antibiotics (tetracyclines, quinolones), cardiac glycosides (digoxin, digitoxin), levothyroxine (a thyroid hormone), eltrombopag (a medicine used to increase the number of platelets) or other prescribed medicines (e.g. fluorides, phosphate, iron containing products) speak to your doctor before taking Rennie Dual Action Tablets because it can affect how these medicines work. To maximise the benefit of all medicines being used, take Rennie Dual Action Tablets 1 to 2 hours after taking any other medicines. If you are taking any thiazide diuretics (e.g. bendroflumethiazide), which are used to increase urine production, then you should tell your doctor before taking the product because he or she may want to monitor the calcium levels in your blood. Important information about some of the ingredients in Rennie Dual Action Tablets: This product contains 28mg of sodium per dose of 2 tablets, which should be taken into consideration by patients on a sodium restricted diet. This product also contains 460mg sucrose and about 1110.44mg glucose (including from dextrates) per dose of 2 tablets, which should be taken into account in patients with diabetes. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product. Pregnancy and breast-feeding: Ask your doctor or pharmacist for advice before taking any medicine. Rennie Dual Action Tablets can be used during pregnancy if taken as instructed. Rennie Dual Action Tablets can be used while breast-feeding if taken as instructed (see Section 3). As Rennie Dual Action Tablets provide a substantial amount of calcium in addition to dietary calcium intake pregnant women should strictly limit their use of Rennie Dual Action Tablets to the maximum recommended daily dose and avoid concomitant, excessive intake of milk (1 litre contains up to 1.2 g elemental calcium) and dairy products. PIL version 1.10, March 2015 2/5

3. HOW TO TAKE RENNIE DUAL ACTION TABLETS Always take Rennie Dual Action Tablets exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure. Adults and children over 12 only: 2 tablets to be chewed, preferably 1 hour after meals and before bedtime. For heartburn an extra 2 tablets may be taken between these times. Do not take more than 12 tablets in 24 hours. Rennie Dual Action Tablets can be used during pregnancy and breast feeding if taken as instructed above. If symptoms persist after 7 days consult your doctor in order to exclude a more serious disease. Prolonged use should be avoided. Do not give to children under the age of 12. If you take more Rennie Dual Action Tablets than you should: Drink plenty of water and consult your doctor or pharmacist. Symptoms of an overdose include nausea and vomiting, constipation, tiredness, increased urine production, increased thirst, dehydration and abnormal muscular weakness. If you have any questions on the use of this product, ask your doctor or pharmacist. If you forget to take Rennie Dual Action Tablets: Do not take a double dose to make up for a forgotten dose. 4. POSSIBLE SIDE EFFECTS Like all medicines, Rennie Dual Action Tablets can cause side effects, although not everybody gets them. Side effects are unlikely at the recommended dose. Rarely allergic reactions to ingredients have been reported, e.g rashes, itching, difficulty in breathing and swelling of the face, mouth or throat and anaphylactic shock. If you experience these reactions stop treatment immediately and seek medical advice. Long term use of high doses can cause high blood levels of calcium and magnesium, especially in people with kidney conditions. This can cause nausea and vomiting, upset stomach, diarrhoea, tiredness, muscular weakness, confusion, increased urine production, increased thirst and dehydration. Taking Rennie Dual Action with milk or dairy products over a long period of time may cause milk alkali syndrome, which can cause high blood levels of calcium. Specific symptoms of milk alkali syndrome may include impaired sense of taste, headache, kidney problems, fatigue and lumps under the skin. Reporting of side effects: If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via PIL version 1.10, March 2015 3/5

HPRA Pharmacovigilance, Earlsfort Terrace, IRL Dublin 2; Tel: +353 1 6764971; Fax: +353 1 6762517. Website: www.hpra.ie; E-mail: medsafety@hpra.ie. By reporting side effects you can help provide more information on the safety of this medicine. 5. HOW TO STORE RENNIE DUAL ACTION TABLETS Keep out of the reach and sight of children. Do not use Rennie Dual Action Tablets after the expiry date which is stated on the carton and foil after EXP. The expiry date refers to the last day of that month. Do not store above 30 o C. Store in the original package in order to protect from moisture. Medicines should not be disposed of via waste water or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment. 6. FURTHER INFORMATION What Rennie Dual Action Tablets contain: Each chewable tablet contains the active ingredients calcium carbonate (625mg), magnesium carbonate (73.5mg) and alginic acid (150mg). The other ingredients are Sodium hydrogen carbonate, sucrose, glucose monohydrate, povidone, talc, magnesium stearate, dextrates, saccharin sodium, lemon cream flavour (contains lemon oil, lime oil, orange oil, l-menthole, vanilline, maltodextrin, gum arabic, ascorbic acid, butylhydroxyanisol), peppermint flavour (contains peppermint oil, maltodextrin, gum arabic, silicon dioxide). What Rennie Dual Action Tablets look like and the contents of the pack: Rennie Dual Action Tablets are off white, speckled circular chewable tablets, flat on both sides with a bevelled edge. They are supplied in foil strips in a carton with this leaflet. The tablets are available in pack-sizes of 12, 18, 24, 30 and 36. Not all pack sizes may be marketed. Marketing Authorisation Holder Bayer Limited The Atrium Blackthorn Road Dublin 18 Manufacturer Delpharm Gaillard 33 rue de l Industrie 74240 Gaillard France PIL version 1.10, March 2015 4/5

This medicinal product is authorised in the Member States of the EEA under the following names: The Netherlands: Rennie Duo Ireland: Rennie Dual Action UK: Rennie Extra This leaflet was last revised in March 2015. PIL version 1.10, March 2015 5/5